Cargando…
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
The liposome is the first nanomedicine transformed into the market and applied to human patients. Since then, such phospholipid bilayer vesicles have undergone technological advancements in delivering small molecular-weight compounds and biological drugs. Numerous investigations about liposome uses...
Autores principales: | He, Yonglong, Zhang, Wanting, Xiao, Qingqing, Fan, Lifang, Huang, Dechun, Chen, Wei, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671608/ https://www.ncbi.nlm.nih.gov/pubmed/36415834 http://dx.doi.org/10.1016/j.ajps.2022.11.002 |
Ejemplares similares
-
Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis
por: Lyu, Yaqi, et al.
Publicado: (2019) -
Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis
por: Wang, Chunxiao, et al.
Publicado: (2023) -
Amphiphilic nanoparticles generate curvature in lipid membranes and shape liposome–liposome interfaces
por: Lavagna, E., et al.
Publicado: (2021) -
Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
por: Zhang, Wei, et al.
Publicado: (2018) -
Effects of the protein corona on liposome–liposome and liposome–cell interactions
por: Corbo, Claudia, et al.
Publicado: (2016)